Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
CD79B mutation
i
Other names:
CD79B, B-Cell Antigen Receptor Complex-Associated Protein Beta Chain, CD79b Molecule, Immunoglobulin-Associated Beta, Immunoglobulin-Associated B29 Protein, B-Cell-Specific Glycoprotein B29, Ig-Beta, IGB, B29, CD79b Antigen (Immunoglobulin-Associated Beta), CD79B Antigen (Immunoglobulin-Associated Beta), CD79b Antigen, AGM6
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
974
Related biomarkers:
Expression
Mutation
‹
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
CD79B mutation
Diffuse Large B Cell Lymphoma
CD79B mutation
Diffuse Large B Cell Lymphoma
zanubrutinib
Sensitive: C2 – Inclusion Criteria
zanubrutinib
Sensitive
:
C2
zanubrutinib
Sensitive: C2 – Inclusion Criteria
zanubrutinib
Sensitive
:
C2
CD79B mutation
Diffuse Large B Cell Lymphoma
CD79B mutation
Diffuse Large B Cell Lymphoma
rituximab + zanubrutinib
Sensitive: C2 – Inclusion Criteria
rituximab + zanubrutinib
Sensitive
:
C2
rituximab + zanubrutinib
Sensitive: C2 – Inclusion Criteria
rituximab + zanubrutinib
Sensitive
:
C2
CD79B mutation
Diffuse Large B Cell Lymphoma
CD79B mutation
Diffuse Large B Cell Lymphoma
methotrexate
Sensitive: C3 – Early Trials
methotrexate
Sensitive
:
C3
methotrexate
Sensitive: C3 – Early Trials
methotrexate
Sensitive
:
C3
CD79B mutation
Lymphoma
CD79B mutation
Lymphoma
ibrutinib
Sensitive: C3 – Early Trials
ibrutinib
Sensitive
:
C3
ibrutinib
Sensitive: C3 – Early Trials
ibrutinib
Sensitive
:
C3
CD79B mutation
Diffuse Large B Cell Lymphoma
CD79B mutation
Diffuse Large B Cell Lymphoma
inotuzumab ozogamicin
Sensitive: C3 – Early Trials
inotuzumab ozogamicin
Sensitive
:
C3
inotuzumab ozogamicin
Sensitive: C3 – Early Trials
inotuzumab ozogamicin
Sensitive
:
C3
CD79B mutation
Diffuse Large B Cell Lymphoma
CD79B mutation
Diffuse Large B Cell Lymphoma
JNJ-6633 + JNJ-4681
Sensitive: D – Preclinical
JNJ-6633 + JNJ-4681
Sensitive
:
D
JNJ-6633 + JNJ-4681
Sensitive: D – Preclinical
JNJ-6633 + JNJ-4681
Sensitive
:
D
CD79B mutation
Diffuse Large B Cell Lymphoma
CD79B mutation
Diffuse Large B Cell Lymphoma
JNJ-4681
Sensitive: D – Preclinical
JNJ-4681
Sensitive
:
D
JNJ-4681
Sensitive: D – Preclinical
JNJ-4681
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.